Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis

Table 1

Basic information of eligible studies for miR-206.

Study	Year	Country	Study type	Tumor type	Sample size	Detected sample	Detected method	Analysis type	Survival analysis	Source of HR	NOS score
Wang	2013	China	R	Astrocytomas	108	Tissue	qRT-PCR	Univariate	OS	Reported	6
Tian	2015	China	R	Melanoma	60	Serum	qRT-PCR	Multivariate	OS, DFS	Reported	6
Yang	2013	China	R	GC	98	Tissue	qRT-PCR	Multivariate	OS	Reported	7
Liu	2017	China	R	CRC	73	Serum	qRT-PCR	Multivariate	OS, DFS	Reported	6
Zhang	2014	China	R	Osteosarcoma	100	Serum	qRT-PCR	Multivariate	OS, DFS	Reported	6
Shi	2015	China	R	GC	220	Tissue	qRT-PCR	Multivariate	OS	Reported	7
Sun	2015	China	R	CRC	80	Tissue	qRT-PCR	Multivariate	OS	Reported	7
Chen	2017	China	R	CC	41	Tissue	qRT-PCR	Multivariate	OS	SC	7
Cui	2018	China	R	CC	56	Tissue	qRT-PCR	Univariate	OS	SC	6
Hou	2016	China	R	GC	150	Serum	qRT-PCR	Multivariate	OS, DFS	SC	7
Ling	2014	China	R	CC	66	Tissue	qRT-PCR	Multivariate	OS	SC	7
Liu	2019	China	R	AML	73	Serum	qRT-PCR	Univariate	OS, DFS	SC	7
Xue	2016	China	R	NSCLC	116	Tissue	qRT-PCR	Univariate	OS	Reported	6
Guo	2020	China	R	RCC	60	Tissue	qRT-PCR	Multivariate	OS	Reported	7
Chen	2019	China	R	RCC	46	Tissue	qRT-PCR	Univariate	OS	SC	6
Zhang	2019	China	R	ESCC	52	Tissue	qRT-PCR	Univariate	OS	SC	6
Missiaglia	2010	UK	R	RMS	119	Tissue	qRT-PCR	Multivariate	OS	Reported	7
Heinemann	2018	Germany	R	RCC	68	Serum	qRT-PCR	Univariate	OS, PFS	SC	6
Quan	2018	China	R	BC	372	Tissue	qRT-PCR	Univariate	OS	SC	6
Han	2017	China	R	CC	131	Serum	qRT-PCR	Univariate	DFS	SC	7

Abbreviation: R: retrospective; P: prospective; RMS: rhabdomyosarcomas; BC: breast cancer; GC: gastric cancer; RCC: renal cell carcinomas; CRC: colorectal cancer; AML: acute myeloid leukemia; CC: cervical cancer; ESCC: esophageal squamous cell carcinoma; OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; SC: survival curve.